// App-Quantinova.ai

: Quality of life in severe asthma measured by SAQ and EQ5D questionnaires as a function of clinically relevant cut off points

Researchers

Presenter

  • Joseph Lanario

Principal Investigators

  • Rupert Jones

  • Michael Hyland

  • Andrew Menzies-Gow

  • Adel Mansur

  • James Dodd

  • Stephen Fowler

  • Mitesh Patel

  • Gemma Hayes

  • Matthew Masoli

Medical Centers

  • Faculty of Health: Medicine, Dentistry & Human Sciences University of Plymouth, Plymouth, United Kingdom

  • Research Department, Plymouth Marjon University, Plymouth, United Kingdom

  • Department of Anaesthesia, Royal Brompton Hospital, London, United Kingdom

  • Department of Respiratory Medicine, Heartlands Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom

  • Academic Rheumatology, University of West of England, Bristol, United Kingdom

  • Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, United Kingdom, Manchester, United Kingdom

  • University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom.

  • University of Exeter, College of Medicine and Health, Exeter, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cross-Sectional

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved